345 related articles for article (PubMed ID: 9813253)
1. Designed beta-sheet-forming peptide 33mers with potent human bactericidal/permeability increasing protein-like bactericidal and endotoxin neutralizing activities.
Mayo KH; Haseman J; Ilyina E; Gray B
Biochim Biophys Acta; 1998 Sep; 1425(1):81-92. PubMed ID: 9813253
[TBL] [Abstract][Full Text] [Related]
2. Probing structure-activity relationships in bactericidal peptide betapep-25.
Dings RP; Haseman JR; Mayo KH
Biochem J; 2008 Aug; 414(1):143-50. PubMed ID: 18489259
[TBL] [Abstract][Full Text] [Related]
3. B/PI-derived synthetic peptides: synergistic effects in tethered bactericidal and endotoxin neutralizing peptides.
Gray BH; Haseman JR; Mayo KH
Biochim Biophys Acta; 1995 May; 1244(1):185-90. PubMed ID: 7766657
[TBL] [Abstract][Full Text] [Related]
4. Topomimetics of amphipathic beta-sheet and helix-forming bactericidal peptides neutralize lipopolysaccharide endotoxins.
Chen X; Dings RP; Nesmelova I; Debbert S; Haseman JR; Maxwell J; Hoye TR; Mayo KH
J Med Chem; 2006 Dec; 49(26):7754-65. PubMed ID: 17181157
[TBL] [Abstract][Full Text] [Related]
5. Structure-function relationships in novel peptide dodecamerswith broad-spectrum bactericidal and endotoxin-neutralizing activities.
Mayo KH; Haseman J; Young HC; Mayo JW
Biochem J; 2000 Aug; 349 Pt 3(Pt 3):717-28. PubMed ID: 10903132
[TBL] [Abstract][Full Text] [Related]
6. Bactericidal activity of synthetic peptides based on the structure of the 55-kilodalton bactericidal protein from human neutrophils.
Gray BH; Haseman JR
Infect Immun; 1994 Jul; 62(7):2732-9. PubMed ID: 8005662
[TBL] [Abstract][Full Text] [Related]
7. Structure/function studies of an endotoxin-neutralizing peptide derived from bactericidal/permeability-increasing protein.
Wasiluk KR; Leslie DB; Vietzen PS; Mayo KH; Dunn DL
Surgery; 2004 Aug; 136(2):253-60. PubMed ID: 15300188
[TBL] [Abstract][Full Text] [Related]
8. A folding pathway for betapep-4 peptide 33mer: from unfolded monomers and beta-sheet sandwich dimers to well-structured tetramers.
Mayo KH; Ilyina E
Protein Sci; 1998 Feb; 7(2):358-68. PubMed ID: 9521112
[TBL] [Abstract][Full Text] [Related]
9. Designed beta-sheet peptides that inhibit proliferation and induce apoptosis in endothelial cells.
Mayo KH; van der Schaft DW; Griffioen AW
Angiogenesis; 2001; 4(1):45-51. PubMed ID: 11824378
[TBL] [Abstract][Full Text] [Related]
10. Design of a potent novel endotoxin antagonist.
Uknis ME; Wasiluk KR; Acton RD; Klaerner HG; Dahlberg PS; Ilyina EE; Haseman JR; Gray BH; Mayo KH; Dunn DL
Surgery; 1997 Aug; 122(2):380-5. PubMed ID: 9288144
[TBL] [Abstract][Full Text] [Related]
11. A peptide derived from human bactericidal/permeability-increasing protein (BPI) exerts bactericidal activity against Gram-negative bacterial isolates obtained from clinical cases of bovine mastitis.
Chockalingam A; McKinney CE; Rinaldi M; Zarlenga DS; Bannerman DD
Vet Microbiol; 2007 Nov; 125(1-2):80-90. PubMed ID: 17560054
[TBL] [Abstract][Full Text] [Related]
12. Antimicrobial activity of bovine bactericidal permeability-increasing protein-derived peptides against gram-negative bacteria isolated from the milk of cows with clinical mastitis.
Chockalingam A; Zarlenga DS; Bannerman DD
Am J Vet Res; 2007 Nov; 68(11):1151-9. PubMed ID: 17975968
[TBL] [Abstract][Full Text] [Related]
13. Structure, activity and interactions of the cysteine deleted analog of tachyplesin-1 with lipopolysaccharide micelle: Mechanistic insights into outer-membrane permeabilization and endotoxin neutralization.
Saravanan R; Mohanram H; Joshi M; Domadia PN; Torres J; Ruedl C; Bhattacharjya S
Biochim Biophys Acta; 2012 Jul; 1818(7):1613-24. PubMed ID: 22464970
[TBL] [Abstract][Full Text] [Related]
14. Acylation of SC4 dodecapeptide increases bactericidal potency against Gram-positive bacteria, including drug-resistant strains.
Lockwood NA; Haseman JR; Tirrell MV; Mayo KH
Biochem J; 2004 Feb; 378(Pt 1):93-103. PubMed ID: 14609430
[TBL] [Abstract][Full Text] [Related]
15. Endotoxin-binding synthetic peptides with endotoxin-neutralizing, antibacterial and anticoagulant activities.
Hirata M; Shimomura Y; Yoshida M; Wright SC; Larrick JW
Prog Clin Biol Res; 1994; 388():147-59. PubMed ID: 7831355
[TBL] [Abstract][Full Text] [Related]
16. Designing potent antimicrobial peptides by disulphide linked dimerization and N-terminal lipidation to increase antimicrobial activity and membrane perturbation: Structural insights into lipopolysaccharide binding.
Datta A; Kundu P; Bhunia A
J Colloid Interface Sci; 2016 Jan; 461():335-345. PubMed ID: 26407061
[TBL] [Abstract][Full Text] [Related]
17. A synthetic peptide derived from bactericidal/permeability-increasing protein neutralizes endotoxin in vitro and in vivo.
Jiang Z; Hong Z; Guo W; Xiaoyun G; Gengfa L; Yongning L; Guangxia X
Int Immunopharmacol; 2004 Apr; 4(4):527-37. PubMed ID: 15099530
[TBL] [Abstract][Full Text] [Related]
18. Peptide derivatives of three distinct lipopolysaccharide binding proteins inhibit lipopolysaccharide-induced tumor necrosis factor-alpha secretion in vitro.
Battafaraono RJ; Dahlberg PS; Ratz CA; Johnston JW; Gray BH; Haseman JR; Mayo KH; Dunn DL
Surgery; 1995 Aug; 118(2):318-24. PubMed ID: 7638748
[TBL] [Abstract][Full Text] [Related]
19. Human bactericidal/permeability-increasing protein and a recombinant NH2-terminal fragment cause killing of serum-resistant gram-negative bacteria in whole blood and inhibit tumor necrosis factor release induced by the bacteria.
Weiss J; Elsbach P; Shu C; Castillo J; Grinna L; Horwitz A; Theofan G
J Clin Invest; 1992 Sep; 90(3):1122-30. PubMed ID: 1522221
[TBL] [Abstract][Full Text] [Related]
20. Modulation of structure and antibacterial and hemolytic activity by ring size in cyclic gramicidin S analogs.
Kondejewski LH; Farmer SW; Wishart DS; Kay CM; Hancock RE; Hodges RS
J Biol Chem; 1996 Oct; 271(41):25261-8. PubMed ID: 8810288
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
